GlassScriptPhysician profile
Nathan R Starke
NPI 1386936680
$50,391.79
in general payments reported to CMS, 2019-2025
24 companies · $83.51 in 2025
The $83.51 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,299 · 2020: $2,262 · 2021: $6,824 · 2022: $22K · 2023: $11K · 2024: $1,559 · 2025: $83.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,500 · Food and Beverage: $3,145 · Travel and Lodging: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,500.00 |
| Food and Beverage | $3,145.39 |
| Travel and Lodging | $1,536.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $18,452.09 | 2020-2024 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $10,170.62 | 2019-2024 | Ams 700, Ams 700 Cxr Rte Kit |
| Endo Pharmaceuticals INC. | $7,228.83 | 2019-2024 | Xiaflex, Aveed |
| Acerus Pharmaceuticals Corporation | $7,170.46 | 2022 | |
| Coloplast Corp | $3,510.42 | 2019-2024 | Titan |
| Teleflex LLC | $1,960.11 | 2021-2025 | Urolift |
| Neotract INC. | $391.24 | 2019 | |
| Axonics, INC. | $278.08 | 2020-2023 | Axonics |
| Intuitive Surgical, INC. | $212.98 | 2019 | |
| Astellas Pharma US INC | $163.37 | 2019-2022 | |
| Biotissue Holdings INC. | $163.25 | 2022-2023 | |
| Halozyme INC | $155.70 | 2023 | |
| Sumitomo Pharma America, INC. | $133.25 | 2023-2024 | Gemtesa |
| Procept Biorobotics Corporation | $129.27 | 2019-2020 | |
| Baxter Healthcare | $47.21 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $41.38 | 2024 | Xiaflex, Aveed |
| Urovant Sciences INC | $32.97 | 2022 | |
| 180 Medical, INC. | $31.30 | 2023 | |
| Abbvie INC. | $25.29 | 2022 | |
| Novo Nordisk INC | $24.16 | 2024 | Rivfloza |
| Alafair Biosciences, INC. | $21.73 | 2022 | |
| Pfizer INC. | $20.39 | 2019 | |
| Urogen Pharma, INC. | $16.11 | 2022 | |
| Rigicon,INC. | $11.58 | 2023 | Rigi10 Malleable Penile Prosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Starke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.